Global Tissue Diagnostics Market Size study, By Product (Consumables, Instruments), By Technology (Immunohistochemistry, In Situ Hybridization, Digital Pathology and Workflow, Special Staining), By Disease (Breast Cancer, Non-small Cell Lung Cancer, Prost

Global Tissue Diagnostics Market Size study, By Product (Consumables, Instruments), By Technology (Immunohistochemistry, In Situ Hybridization, Digital Pathology and Workflow, Special Staining), By Disease (Breast Cancer, Non-small Cell Lung Cancer, Prostate Cancer, Gastric Cancer, Other Cancers), By End-User (Hospitals, Research Laboratories, Others), and Regional Forecasts 2022-2028

Global Tissue Diagnostics Market is valued at approximately USD XX million in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2028. Tissue diagnostic is a procedure of monitoring, diagnosis, and management of a tissue sample for cancer diagnosis and other target disorders. The rising prevalence of cancer, increasing advancements in imaging techniques, and increasing affordability of diagnostics, coupled with the growth of personalized therapeutics and diagnostics are the primary factors that are burgeoning the global market growth. According to National Cancer Institute, in 2018, cancer patients were recorded at 18.1 million, and the figure increases and is expected to reach 29.5 million cases by 2040. Thereby, the growing incidences of cancer are fueling the demand for Tissue Diagnostics, which, in turn, augments the market growth around the world. However, high costs associated with R&D and clinical trials and strict regulatory requirements impede the growth of the market over the forecast period of 2022-2028. Also, the rising number of clinical trials pertaining to cancer drugs and the increasing number of private diagnostics centers are anticipated to act as catalyzing factors for the market demand during the forecast period.

The key regions considered for the global Tissue Diagnostics Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading region across the world in terms of market share owing to the easy accessibility to advanced technologies and surging demand for cancer diagnosis supplements. Whereas, Asia-Pacific is anticipated to exhibit the highest CAGR over the forecast period 2022-2028. Factors such as the rapidly growing aging population, as well as the rising prevalence of chronic lifestyle & genetic diseases, would create lucrative growth prospects for the Tissue Diagnostics Market across the Asia-Pacific region.

Major market players included in this report are:
F. Hoffmann-La Roche Ltd.
Danaher Corporation
Thermo Fisher Scientific, Inc
Abbott
Agilent Technologies Inc.
Merck KGAA
Sakura Finetek Japan Co., Ltd
Abcam Plc.
Becton, Dickinson and Company
Cell Signaling Technology, Inc

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product Products of key players. The detailed segments and sub-segment of the market are explained below:
By Product:
Consumables
Instruments
By Technology:
Immunohistochemistry
In Situ Hybridization
Digital Pathology and Workflow
Special Staining
By Disease:
Breast Cancer
Non-small Cell Lung Cancer
Prostate Cancer
Gastric Cancer
Other Cancers
By End-User:
Hospitals
Research Laboratories
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028

Target Audience of the Global Tissue Diagnostics Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

Companies Mentioned

F. Hoffmann-La Roche Ltd.
Danaher Corporation
Thermo Fisher Scientific, Inc
Abbott
Agilent Technologies Inc.
Merck KGAA
Sakura Finetek Japan Co., Ltd
Abcam Plc.
Becton, Dickinson and Company
Cell Signaling Technology, Inc

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.